Table 1.
Demographic and Disease-Related Characteristics of Patients Confirmed with COVID-19
| Total (n=190) | Severe (n=32) | Non-Severe (n=158) | Z/x2/t | p | ||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |||
| Age (M, SD) a | 55.70 | 13.70 | 61.55 | 13.10 | 54.54 | 13.56 | 2.644 | 0.009 |
| 18–40 | 33 | 17.4 | 2 | 6.3 | 31 | 19.6 | ||
| 41–60 | 69 | 36.3 | 9 | 28.1 | 60 | 38.0 | ||
| ≥60 | 81 | 42.6 | 21 | 65.6 | 60 | 38.0 | ||
| Missing values | 7 | 3.7 | 0 | 0.000 | 7 | 4.4 | ||
| Gender b | ||||||||
| Male | 87 | 45.8 | 16 | 50.0 | 71 | 44.9 | 0.094 | 0.759 |
| Female | 96 | 50.5 | 16 | 50.0 | 80 | 50.6 | ||
| Missing values | 7 | 3.7 | 0 | 0.0 | 7 | 4.4 | ||
| Family members or acquaintances infected b | ||||||||
| No | 95 | 50.0 | 18 | 56.3 | 77 | 48.7 | 0.292 | 0.589 |
| Yes | 88 | 46.3 | 14 | 43.8 | 74 | 46.8 | ||
| Missing values | 7 | 3.7 | 0 | 0 | 7 | 4.4 | ||
| Symptom onset to, days a | Median | (IQR) | Median | (IQR) | Median | (IQR) | ||
| First Medical Visit | 2 | (1–5) | 3 | (1–11) | 2 | (0–5) | −1.625 | 0.104 |
| Hospitalization | 16 | (10–27) | 18.5 | (11.25–29.75) | 16 | (9–26) | −0.875 | 0.382 |
| Missing values | 9 | 0 | 8 | |||||
| Lymphocyte count, ×10^9/L b | 1.5 | (1.11–1.96) | 1.19 | (0.63–1.53) | 1.57 | (1.18–2.00) | −3.775 | <0.001 |
| ≥1.5 | 122 | 64.2 | 15 | 46.9 | 107 | 67.7 | ||
| <1.5 | 62 | 32.6 | 17 | 53.1 | 45 | 28.5 | ||
| Missing values | 6 | 3.2 | 0 | 0 | 6 | 3.8 | ||
| The lowest SaO2, % b | 96 | (95–98) | 93 | (90–96) | 96 | (96–98) | −5.048 | <0.001 |
| >93% | 164 | 86.3 | 13 | 40.6 | 151 | 95.6 | ||
| ≤93% | 25 | 13.2 | 19 | 59.4 | 6 | 3.8 | ||
| Missing values | 1 | 0.5 | 0 | 0 | 1 | 0.6 | ||
| Sleep quality c | Mean | SD | Mean | SD | Mean | SD | ||
| Subjective sleep quality | 1.32 | 0.88 | 1.22 | 0.94 | 1.34 | 0.87 | −0.718 | 0.474 |
| Difficulty falling asleep | 1.36 | 1.06 | 1.31 | 1.09 | 1.37 | 1.05 | −0.265 | 0.791 |
| Frequent nocturnal or early morning awakening | 1.49 | 1.07 | 1.50 | 1.16 | 1.49 | 1.05 | 0.061 | 0.951 |
| Sleep duration | 1.49 | 1.04 | 1.53 | 0.98 | 1.49 | 1.05 | 0.218 | 0.828 |
| PCL-5 c | ||||||||
| Total score | 17.69 | 13.95 | 17.00 | 12.31 | 17.83 | 14.29 | −0.306 | 0.760 |
| Criterion B | 5.15 | 4.49 | 5.22 | 4.27 | 5.14 | 4.54 | 0.091 | 0.927 |
| Criterion C | 2.25 | 2.08 | 2.19 | 2.28 | 2.26 | 2.05 | −0.178 | 0.859 |
| Criterion D | 5.22 | 4.83 | 5.09 | 4.15 | 5.24 | 4.97 | −0.156 | 0.876 |
| Criterion E | 5.07 | 4.19 | 4.50 | 3.53 | 5.19 | 4.31 | −0.849 | 0.397 |
| High PTSD symptoms b | ||||||||
| Yes | 43 | 22.6 | 5 | 15.6 | 38 | 24.1 | 1.080 | 0.300 |
| No | 147 | 77.4 | 27 | 84.4 | 120 | 75.9 | ||
Notes:aMann–Whitney U-test; bChi-square test; ct-test.